Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272556 · ClinicalTrials.gov registry record · NA
Investigating the Role of the Polyol Pathway in the Central Nervous System
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
NCT02272556 is a NA study that has completed, run by Yale University. The registered enrollment target is 138 participants.
The verdict
NCT02272556, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
Study Summary
Patients will undergo magnetic resonance spectroscopy (MRS) scanning to noninvasively measure intracerebral and plasma metabolite levels at baseline and following 2 and 4 hours of hyperglycemia. Subjects will also undergo a lumbar puncture at a separate occasion to assess cerebrospinal fluid levels of metabolites.
Interventions
- OTHER Brain MRS during hyperglycemic clamp
- OTHER Analysis of Metabolites in cerebrospinal fluid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2015-02 |
| Est. Completion | 2022-05-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02272556
The ClinicalTrials.gov registry entry for NCT02272556 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Brain MRS during hyperglycemic clamp is the first listed.
NCT02272556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02272556 about?
NCT02272556 is a clinical study titled "Investigating the Role of the Polyol Pathway in the Central Nervous System". Patients will undergo magnetic resonance spectroscopy (MRS) scanning to noninvasively measure intracerebral and plasma metabolite levels at baseline and following 2 and 4 hours of hyperglycemia. Subjects will also undergo a lumbar puncture at a separate occasion to assess cerebrospinal fluid levels ...
What is the current status of trial NCT02272556?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2015-02. Estimated completion is 2022-05-18.
What interventions are being tested in trial NCT02272556?
The interventions under investigation include: Brain MRS during hyperglycemic clamp (OTHER), Analysis of Metabolites in cerebrospinal fluid (OTHER).
Who is sponsoring clinical trial NCT02272556?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.